Cathepsin D improves the prediction of undetected diabetes in patients with myocardial infarction

Cathepsin D improves the prediction of undetected diabetes in patients with myocardial infarction

Background: Newer therapeutic agents for type 2 diabetes mellitus can improve cardiovascular outcomes, but diabetes remains underdiagnosed in patients with myocardial infarction (MI). We sought to identify proteomic markers of undetected dysglycaemia (impaired fasting glucose, impaired glucose toler...

Full description

Bibliographic Details
Main Authors: Matthijs A. Velders, Fredrik Calais, Nina Dahle, Tove Fall, Emil Hagström, Jerzy Leppert, Christoph Nowak, Åke Tenerz, Johan Ärnlöv, Pär Hedberg
Format: Article
Language:English
Published: Upsala Medical Society 2019-07-01
Series:Upsala Journal of Medical Sciences
Subjects:
acute myocardial infarction
biomarkers
diabetes mellitus
proteomics
Online Access:http://dx.doi.org/10.1080/03009734.2019.1650141

Similar Items

Similar Items